ASSESSMENT OF DIABETES MELLITUS AND RISK OF BREAST CANCER: A PROSPECTIVE STUDY ON THE LOCAL POPULATION

M HASSAN; MN AHMED; M IDREES; I AKRAM; A AIJAZ; FR MALIK; A SADDIQA

doi:10.54112/bcsrj.v2023i1.564

Authors

M HASSAN Department of Oncology, Liaquat National Hospital, Karachi, Pakistan
MN AHMED Shifa College Of Nursing Shifa Tameer-E-Millat University, Pakistan
M IDREES Department Of Urology , Saidu Group Of Teaching Hospital Swat KPK, Pakistan
I AKRAM Faculty of Food Science and Nutrition, Bahauddin Zakariya University, Multan, Pakistan
A AIJAZ Aga Khan University Hospital Karachi, Pakistan
FR MALIK Department of Community Health Sciences, Peshawar Medical College, Peshawar/ Riphah International University, Islamabad, Pakistan.
A SADDIQA Department of chemistry, Government College University Faisalabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.564

Keywords:

Diabetes Mellitus, Breast Cancer, Hormonal Factors, Risk Assessment, Retrospective Studies

Abstract

Diabetes mellitus (DM), characterized by impaired insulin function or resistance, has gained prominence as a multifaceted health concern. Recent epidemiological studies suggest a potential link between DM and breast cancer risk. This retrospective cohort study, conducted in a Liaquat National Hospital, Karachi from January 2022 to June 2023, aimed to investigate the role of DM in the risk of breast cancer in a population of 120 participants with documented diabetes diagnoses. The participants, with a mean age of 55±8.1 years and fair glycemic control (HbA1c: 7.5%), exhibited a 30% higher likelihood of breast cancer, as indicated by a statistically significant odds ratio of 1.30 (95% CI: 1.05 - 1.60, p < 0.05). Hormonal analyses revealed mean insulin levels of 45 μU/mL, IGF-1 at 150 ng/mL, estrogen at 30 pg/mL, and SHBG at 40 nmol/L in the subset with DM Stratifying by menopausal status and diabetes duration revealed nuanced associations, emphasizing the importance of considering these factors in understanding the DM-breast cancer relationship. Notably, individuals with diabetic nephropathy demonstrated 40% higher odds of breast cancer, remaining significant after adjustments. This study sheds light on the intricate connections between DM and breast cancer risk, emphasizing the need for tailored screening, surveillance, and preventive strategies in clinical management.

Downloads

Download data is not yet available.

References

Carstensen, B., Read, S., Friis, S., Sund, R., Keskimaki, I., Svensson, A.-M., Ljung, R., Wild, S., Kerssens, J. J., and Harding, J. (2016). Cancer incidence in persons with type 1 diabetes: A 5-country study of 9,000 cancers in persons with type 1 diabetes. Diabetologia 59.

Cuadros, D. F., Li, J., Musuka, G., and Awad, S. F. (2021). Spatial epidemiology of diabetes: Methods and insights. World journal of diabetes 12, 1042.

De Hert, M., Peuskens, J., Sabbe, T., Mitchell, A., Stubbs, B., Neven, P., Wildiers, H., and Detraux, J. (2016). Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatrica Scandinavica 133, 5-22.

His, M., Viallon, V., Dossus, L., Gicquiau, A., Achaintre, D., Scalbert, A., Ferrari, P., Romieu, I., Onland-Moret, N. C., and Weiderpass, E. (2019). Prospective analysis of circulating metabolites and breast cancer in EPIC. BMC medicine 17, 1-13.

Kirtonia, A., Gala, K., Fernandes, S. G., Pandya, G., Pandey, A. K., Sethi, G., Khattar, E., and Garg, M. (2021). Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics. In "Seminars in cancer biology", Vol. 68, pp. 258-278. Elsevier.

Larsson, S. C., Mantzoros, C. S., and Wolk, A. (2007). Diabetes mellitus and risk of breast cancer: a meta‐analysis. International journal of cancer 121, 856-862.

Momenimovahed, Z., and Salehiniya, H. (2019). Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer: Targets and Therapy, 151-164.

Overbeek, J. A., van Herk-Sukel, M. P., Vissers, P. A., van der Heijden, A. A., Bronsveld, H. K., Herings, R. M., Schmidt, M. K., and Nijpels, G. (2019). Type 2 diabetes, but not insulin (analog) treatment, is associated with more advanced stages of breast cancer: a national linkage of cancer and pharmacy registries. Diabetes Care 42, 434-442.

Park, Y.-M., Bookwalter, D., O'Brien, K., Jackson, C., Weinberg, C., and Sandler, D. (2021). A prospective study of type 2 diabetes, metformin use, and risk of breast cancer. Annals of Oncology 32, 351-359.

Ramteke, P., Deb, A., Shepal, V., and Bhat, M. K. (2019). Hyperglycemia associated metabolic and molecular alterations in cancer risk, progression, treatment, and mortality. Cancers 11, 1402.

Roshan, M. H., Shing, Y. K., and Pace, N. P. (2019). Metformin as an adjuvant in breast cancer treatment. SAGE open medicine 7, 2050312119865114.

Shao, S., Gill, A. A., Zahm, S. H., Jatoi, I., Shriver, C. D., McGlynn, K. A., and Zhu, K. (2018). Diabetes and overall survival among breast cancer patients in the US military health system. Cancer Epidemiology, Biomarkers & Prevention 27, 50-57.

Wang, L., Zhang, H.-J., Liu, Y.-F., and Chen, G.-Y. (2021). Impact of insulin use on outcomes of diabetic breast cancer patients: a systematic review and meta-analysis. European Review for Medical & Pharmacological Sciences 25.

Wijas, K., Szala-Czerwonka, K., Rejmer, A., Woś, N., Rojek, K., Bednarz, L., Bialic, K., Bakalarczyk, R., Bialic, A., and Majewski, P. (2023). Is breast cancer a civilization disease? Common components of type 2 diabetes and breast cancer. Journal of Education, Health and Sport 24, 80-86.

Wojciechowska, J., Krajewski, W., Bolanowski, M., Kręcicki, T., and Zatoński, T. (2016). Diabetes and cancer: a review of current knowledge. Experimental and Clinical Endocrinology & Diabetes 124, 263-275.

Wolf, I., Sadetzki, S., Catane, R., Karasik, A., and Kaufman, B. (2005). Diabetes mellitus and breast cancer. The lancet oncology 6, 103-111.

Wu, J. W., Azoulay, L., Majdan, A., Boivin, J.-F., Pollak, M., and Suissa, S. (2017). Long-term use of long-acting insulin analogs and breast cancer incidence in women with type 2 diabetes. Journal of Clinical Oncology 35, 3647-3653.

Xiong, F., Wang, J., Nierenberg, J. L., Van Blarigan, E. L., Kenfield, S. A., Chan, J. M., Schmajuk, G., Huang, C.-Y., and Graff, R. E. (2023). Diabetes mellitus and risk of breast cancer: A large-scale, prospective, population-based study. British Journal of Cancer 129, 648-655.

Youn, H. J., and Han, W. (2020). A review of the epidemiology of breast cancer in Asia: Focus on risk factors. Asian Pacific journal of cancer prevention: APJCP 21, 867.